Arcellx (ACLX) Payables (2021 - 2025)
Arcellx (ACLX) recorded quarterly Payables of $5.6 million in Q4 2025, up 32.64% quarter-over-quarter from $4.2 million in Q3 2025, and up 166.16% on a YoY basis from $2.1 million in Q4 2024.
Arcellx (ACLX) Payables (2021 - 2025) Analysis & Trends
Arcellx's Payables history runs 5 years deep, the most recent figure standing at $5.6 million for Q4 2025.
- In Q4 2025, Payables rose 166.16% year-over-year to $5.6 million; the TTM figure through Dec 2025 stood at $5.6 million (up 166.16% YoY), while the FY2025 annual figure was $5.6 million, up 166.16% from the prior year.
- Payables was $5.6 million for Q4 2025 at Arcellx, up from $4.2 million in the prior quarter.
- In the past five years, Payables ranged from a high of $9.1 million in Q4 2022 to a low of $1.3 million in Q4 2021.
- Historically, Payables has averaged $4.4 million across 5 years, with a median of $4.4 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Payables soared 579.14% in 2022, then slumped 71.07% in 2023.
- A 5-year view of Payables shows it stood at $1.3 million in 2021, then jumped by 579.14% to $9.1 million in 2022, then plunged by 71.07% to $2.6 million in 2023, then slipped by 20.01% to $2.1 million in 2024, then soared by 166.16% to $5.6 million in 2025.
- The last three Payables figures came in at $5.6 million (Q4 2025), $4.2 million (Q3 2025), and $2.1 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 5.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.58 Mn |
| Sep 30, 2025 | 4.20 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Mar 31, 2025 | 4.37 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | 5.99 Mn |
| Jun 30, 2024 | 4.87 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2023 | 7.19 Mn |
| Jun 30, 2023 | 5.69 Mn |
| Mar 31, 2023 | 4.53 Mn |
| Dec 31, 2022 | 9.05 Mn |
| Sep 30, 2022 | 2.96 Mn |
| Jun 30, 2022 | 7.56 Mn |
| Mar 31, 2022 | 1.87 Mn |
| Dec 31, 2021 | 1.33 Mn |